跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
IMATINIB SANDOZ FARMACEUTICA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
IMATINIB SANDOZ FARMACEUTICA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Sandoz Farmaceutica S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 8, 2026
Approval ID
fd53d754f14f5167
Company
Sandoz Farmaceutica S.A.
Type
Standard
Approval Details
Approval Id
fd53d754f14f5167
Drug Cima Aemps Name
IMATINIB SANDOZ FARMACEUTICA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
91490
Holder Company Name
Sandoz Farmaceutica S.A.
Marketing Company Name
Sandoz Farmaceutica S.A.
Authorization Date
2026-09-08
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
400 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Sandoz Farmaceutica S.A.
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 8, 2026
Approval ID
fd53d754f14f5167
Type
Standard
Back to CIMA-AEMPS Approvals
IMATINIB SANDOZ FARMACEUTICA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details